These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24424504)

  • 1. Androgen receptor phosphorylation: biological context and functional consequences.
    Koryakina Y; Ta HQ; Gioeli D
    Endocr Relat Cancer; 2014 Aug; 21(4):T131-45. PubMed ID: 24424504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
    Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-specific regulation of androgen receptor phosphorylation in vivo.
    Taneja SS; Ha S; Swenson NK; Huang HY; Lee P; Melamed J; Shapiro E; Garabedian MJ; Logan SK
    J Biol Chem; 2005 Dec; 280(49):40916-24. PubMed ID: 16210317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization.
    Gioeli D; Black BE; Gordon V; Spencer A; Kesler CT; Eblen ST; Paschal BM; Weber MJ
    Mol Endocrinol; 2006 Mar; 20(3):503-15. PubMed ID: 16282370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor.
    Kasina S; Macoska JA
    Mol Cell Endocrinol; 2012 Apr; 351(2):249-63. PubMed ID: 22245379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting alternative sites on the androgen receptor to treat castration-resistant prostate cancer.
    Lallous N; Dalal K; Cherkasov A; Rennie PS
    Int J Mol Sci; 2013 Jun; 14(6):12496-519. PubMed ID: 23771019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of androgen receptor by PIM-1 kinases via phosphorylation-dependent recruitment of distinct ubiquitin E3 ligases.
    Linn DE; Yang X; Xie Y; Alfano A; Deshmukh D; Wang X; Shimelis H; Chen H; Li W; Xu K; Chen M; Qiu Y
    J Biol Chem; 2012 Jun; 287(27):22959-68. PubMed ID: 22584579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor post-translational modifications and their implications for pathology.
    Montoya-Novoa I; Gardeazábal-Torbado JL; Alegre-Martí A; Fuentes-Prior P; Estébanez-Perpiñá E
    Biochem Soc Trans; 2024 Aug; 52(4):1673-1694. PubMed ID: 38958586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttranslational modification of the androgen receptor in prostate cancer.
    van der Steen T; Tindall DJ; Huang H
    Int J Mol Sci; 2013 Jul; 14(7):14833-59. PubMed ID: 23863692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer.
    Terry S; Yang X; Chen MW; Vacherot F; Buttyan R
    J Cell Biochem; 2006 Oct; 99(2):402-10. PubMed ID: 16741972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor.
    Saporita AJ; Zhang Q; Navai N; Dincer Z; Hahn J; Cai X; Wang Z
    J Biol Chem; 2003 Oct; 278(43):41998-2005. PubMed ID: 12923188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer.
    Reddy GP; Barrack ER; Dou QP; Menon M; Pelley R; Sarkar FH; Sheng S
    J Cell Biochem; 2006 Aug; 98(6):1408-23. PubMed ID: 16619263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen.
    Whitworth H; Bhadel S; Ivey M; Conaway M; Spencer A; Hernan R; Holemon H; Gioeli D
    PLoS One; 2012; 7(6):e38950. PubMed ID: 22761715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer.
    Ha S; Iqbal NJ; Mita P; Ruoff R; Gerald WL; Lepor H; Taneja SS; Lee P; Melamed J; Garabedian MJ; Logan SK
    Oncogene; 2013 Aug; 32(34):3992-4000. PubMed ID: 22986532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor structural and functional elements: role and regulation in prostate cancer.
    Dehm SM; Tindall DJ
    Mol Endocrinol; 2007 Dec; 21(12):2855-63. PubMed ID: 17636035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor-related diseases: what do we know?
    Shukla GC; Plaga AR; Shankar E; Gupta S
    Andrology; 2016 May; 4(3):366-81. PubMed ID: 26991422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.
    Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the androgen receptor by post-translational modifications.
    Coffey K; Robson CN
    J Endocrinol; 2012 Nov; 215(2):221-37. PubMed ID: 22872761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of different androgen receptor domains to receptor dimerization and signaling.
    Centenera MM; Harris JM; Tilley WD; Butler LM
    Mol Endocrinol; 2008 Nov; 22(11):2373-82. PubMed ID: 18617596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.